baber/WOPTO huggingface dataset:
Patent NZ-552023-A (NZ)
Title: Patch for detection of blood leakage from wounds
Inventor: ENGVALL DANIEL
IPC: H04B10/25
Filed: 2005-06-21
Abstract: An optical fibre through which light passes is used for detecting blood leakage from a wound causing attenuation of the light during its passage. The fibre may be comprised by a blood leakage detection apparatus having a light source and a photo detector in radiative communication with the respective ends of the fibre and producing an electrical signal in response to the light detected, photo detector signal amplifying means, means for detecting changes in the amplified signal over time, and alarm means, wherein a decrease in signal strength during a selected time period activates the alarm means; a corresponding method of detecting blood leakage.
Patent NZ-562073-A (NZ)
Title: Portable wound therapy system that removes exudates from a wound using a vacuum generator and collecting it in a container
Inventor: MULLIGAN SHARON
Filed: 2007-09-28
Abstract: A portable sub-atmospheric wound therapy system is disclosed. A wound dressing (102) is applied over a wound (w). The dressing (102) is connected to a housing (104) worn by the patient. The housing (104) contains a source of sub-atmospheric pressure such as a pump, a power source and a storage container. Fluids are drawn from the wound by the pump and deposited in the container for collection. The container has a number of fluid paths for storing the fluids.
Patent NZ-566048-A (NZ)
Title: Secure imaging toner using a disazo dye and methods of forming and using the same
Inventor: RILEY MICHAEL R
IPC: G03G9/09
Filed: 2006-08-10
Abstract: Disclosed is a system using a toner in an electrophotographic printing mechanism producing a secure tamper resistant image on a paper substrate, the toner comprising a colorant for forming an image on a first surface of the paper substrate a visible dye for forming an indelible copy of the surface image in the paper substrate, the visible dye including a disazo compound, whereby the disazo compound diffuses through a portion of the paper substrate only upon coming into contact with a chemical solvent, forming a stain on the paper; and a migration-enhancing agent for aiding the visible dye to form a copy of the surface image in the paper substrate.
Patent NZ-567377-A (NZ)
Title: Macro-control of treatment for sleep disordered breathing
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/06
Filed: 2004-11-25
Abstract: Apparatus for monitoring and treating sleep disordered breathing comprises an inner loop control mechanism adapted to provide at least two treatment modes, and an outer loop control mechanism adapted to monitor the effectiveness of therapy provided by the inner loop control mechanism and to control a change in mode if necessary. The treatment modes provided by the inner loop control mechanism include at least two selected from the group of basic CPAP, automatically adjusting CPAP, bi-Ievel CPAP, and treatment of Cheyne-Stokes respiration. The outer loop control mechanism distinguishes between central and obstructive apneas, or detects oxygen desaturation events, or monitors snoring, or does two or more of these.
Patent NZ-573397-A (NZ)
Title: Device for actuating double seat process valve has separate exhaust lines
Inventor: SPLIETHOFF NORBERT
IPC: F16K31/00
Filed: 2008-12-04
Abstract: A device for actuating a double seat process valve that has first and second cylinders 20, 30 includes at least first and second control valves 101, 103 which each have a connector to be connected to a line 121, 123 of one of the respective cylinders and respective air intake 116 and exhaust connectors. Separate exhaust air lines 104, 105 are provided for the first and second control valves 101, 103 so that compressed air is not inadvertently applied to one of the control valves when the other is vented.
Patent NZ-587545-A (NZ)
Title: Heteroaryl derivatives as cftr modulators
Inventor: HADIDA-RUAH SARA
IPC: G01N27/62
Filed: 2009-02-25
Abstract: Disclosed herein is 1-(benzo[d][1,3]dioxol-5-yl)-N-(2-tosylpyridin-3-yl)cyclopropanecarboxamide of formula I, processes for its preparation, compositions comprising said compound and uses thereof. Said compound is useful as modulators of ATP-Binding Cassette (ABC) transporter or fragments thereof and is therefore useful in the treatment of condition, disease or disorders selected from cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, protein C deficiency, Type 1 hereditary angioedema, familial hypercholesterolemia, Type 1 chylomicronemia, abetalipoproteinemia, I-cell disease/pseudo-Hurler, mucopolysaccharidoses, Sandhof/Tay-Sachs, Crigler-Najjar type II, polyendocrinopathy/hyperinsulemia, diabetes mellitus, laron dwarfism, myleoperoxidase deficiency, primary hypoparathyroidism, melanoma, glycanosis CDG type 1, hereditary emphysema, congenital hyperthyroidism, osteogenesis imperfecta, hereditary hypofibrinogenemia, ACT deficiency, diabetes insipidus (di), neurophyseal di, neprogenic DI, Charcot-Marie Tooth syndrome, Perlizaeus-Merzbacher disease, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, progressive supranuclear plasy, Pick's disease, Huntington, spinocerebullar ataxia type I, spinal and bulbar muscular atrophy, dentatorubal pallidoluysian, myotonic dystrophy, hereditary Creutzfeldt-Jakob disease, Fabry disease, Straussler-Scheinker syndrome, COPD, dry-eye disease, and Sjögren's disease.
Patent NZ-588209-A (NZ)
Title: 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives for the modulation of dopaminergic function in the central nervous system
Inventor: SONESSON CLAS
IPC: A61K31/357
Filed: 2009-04-28
Abstract: Disclosed are 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives of Formula 1, stereoisomers and salts thereof, and methods for their preparation. Specific examples of compounds of formula 1 include: N-{ [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} -propan-1-amine; 2-Methyl-N-{ [(2R)-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} propan-1-amine, 2-Methyl-N-{ [7-(methylsulfony)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} propan-1-amine, and N-{ [(2S)-5-Chloro-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} -N-propylpropan-1amine. Compounds of formula 1 are useful for treating diseases, disorders or conditions responsive to modulation of dopaminergic function in the central nervous system, such as movement disorders, Parkinson's disease, Parkinsonism, dyskinesias, L-DOPA induced dyskinesias, dystonias, tics, tremor, Huntington's disease, iatrogenic psychoses and hallucinoses, non-iatrogenic psychoses and hallucinoses, schizophrenia, schizophreniform disorders, bipolar disorder, mood disorders, anxiety disorders, depression, obsessive-compulsive disease, neurodevelopmental disorders, Autism spectrum disorders, ADHD, Cerebral Palsy, Gilles de la Tourette's syndrome, neurodegenerative disorders, dementia, age-related cognitive impairment, sleep disorders, sexual disorders, eating disorders, obesitas, headaches, pains in conditions characterized by increased muscular tone, substance abuse, Alzheimer's disease or dementia disorders related to Alzheimer's disease.
Patent NZ-593011-A (NZ)
Title: Bimetallic connections for heavy current applications
Inventor: TARRANT MARK
IPC: B23K20/12
Filed: 2011-05-23
Abstract: 593011 Disclosed is a cathode for use in an electrolytic/reduction cell providing increased electrical conductivity and mechanical joint strength between a cathode and electrical contact. The cathode comprises an aluminium head configured for connection to a plurality of aluminium flexible sheets at a first square-end slot connection portion, the aluminium head also comprising a second square-end slot connection portion. A copper electrical contact is configured for connection to the second connection portion. The plurality of aluminium flexible sheets and the first connection portion are electromechanically connected and combined by friction stir welding and the copper electrical contact and the second connection portion are electromechanically connected and combined by friction stir welding. The copper electrical contact comprises a tapered projection configured to be received in the second connection portion.
Patent NZ-598173-A (NZ)
Title: Pyridin-4-yl derivatives
Inventor: MATHYS BORIS
IPC: A61P37/00
Filed: 2010-07-15
Abstract: 598173 Provided are oxadiazole pyridine-4-yl phenyl compounds of formula (I) wherein A, R1, R2, R3, and R4 are as described herein. An example of a preferred compound is (S)-3-{ 4-[5-(2-cyclopentyl-6-methoxypyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy} -propane-1,2-diol. Further provided is the preparation of the compounds and their use as pharmaceutically active compounds. The compounds produce an immunomodulatory effect and can be used in the treatment or prevention of diseases mediated by the immune system including rejection of transplanted organs; graft-versus-host diseases due to stem cell transplantation; autoimmune syndromes including rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, psoriasis, psoriatic arthritis, thyroiditis such as Hashimoto’s thyroiditis, uveo-retinitis; atopic diseases such as rhinitis, conjunctivitis, dermatitis; asthma; type I diabetes; post-infectious autoimmune diseases including rheumatic fever and post-infectious glomerulonephritis; solid cancers and tumour metastasis.
Patent NZ-599382-A (NZ)
Title: Electrical connector
Inventor: ARAKELIAN RICHARD
IPC: B60R16/02
Filed: 2011-04-21
Abstract: An electrical connector for a towed vehicle that includes at least one magnet for temporarily attaching the connector to the towing vehicle or the towed vehicle when not in use. The terminals (102) in the electrical connector are formed of rolled sheet metal, defining a bore into which an electrical wire is accepted. The wire is held in the terminal by a screw (114), which passes through a first aperture (116) in the wall of the rolled sheet and clamps the wire to the opposite wall of the sheet metal. The electrical connector may be round in shape, and the body may be moulded in one piece, or two pieces.
Patent NZ-599986-A (NZ)
Title: Seal, constituent parts of the seal, device and method for arranging such a seal
Inventor: GEENEN KAMIEL REINIER ZALE
IPC: A22B5/14
Filed: 2010-11-10
Abstract: Disclosed is a seal for sealing the esophagus of a slaughtered animal such as a cow. Also claimed is device and a method for sealing the esophagus of a slaughtered animal, such as a cow. The seal comprises a cylindrical body (1) which can be placed in the esophagus and is provided with a cylindrical peripheral wall with an end wall, a clamping element (10) which can be displaced to a clamping position relative to the body for clamping esophageal tissue between at least a part of the clamping element and the cylindrical body, thus fixing the seal in the esophagus and thereby sealing the esophagus. The peripheral wall encloses a receiving space and is provided with an opening through which esophageal tissue can be carried into the receiving space and is there clamped fixedly by the clamping element.
Patent NZ-600515-A (NZ)
Title: Steviol glycoside isomers
IPC: A23L27/30
Filed: 2008-09-04
Abstract: Abstract 600515 Disclosed are compounds of formula (II), wherein R1 is hydrogen and R2 is 2-(1-Beta-D-glucopyranosyl)-1-Beta-D-glucopyranosyl, 2,3-bis(1-Beta-D-glucopyranosyl)-1-Beta-D-glucopyranosyl, 2-(1-Alpha-L-rhamnopyranosyl)-1-Beta-D-glucopyranosyl, 2-(1-Alpha-L-rhamnopyranosyl)-3-(1-Beta-D-glucopyranosyl)-1-Beta-D-glucopyranosyl, or 2-(1-Beta-D-xylopyranosyl)-3-(1-Beta-D-glucopyranosyl)-1-_-Dglucopyranosyl.Further disclosed is a beverage product comprising an aqueous liquid and a compound of formula (II), a food product comprising a food component and a compound of formula (II), and a sweetener comprising a compound of formula (II).Also disclosed is a method for preparing a compound of formula (II), and a compound of formula (II) when prepared by said method.
Patent NZ-602215-A (NZ)
Title: Multi-tier automatic warehouse
Inventor: YAMASHITA SHIN
IPC: B65G1/04
Filed: 2011-03-03
Abstract: Disclosed is an automated storage/retrieval system. The system comprises a first pair of multi-tier racks (12L1); a first pair of waiting stations (24L1); a first transferring shuttle (14); a second pair of multi-tier racks (12L2); a second pair of waiting stations (24L2); a second transferring shuttle (14); an elevator (16); a first conveyer and a second conveyer. The first (12L1) and second (12L2) pairs of multi-tier racks each comprise shelves (22) arranged in parallel to face each other. The first pair of multi-tier racks (12L1) and the second pair of multi-tier racks (12L2) is arranged in series. The first (24L1) and second (24L2) waiting stations are each disposed adjacent to one end of each of the first (12L1) and second (12L2) pairs of multi-tier racks. The first and second transferring shuttles (14) are provided for each tier or every several tiers and waiting conveyers (26L) to allow shuttles (14) to travel horizontally to deliver and retrieve a load (P) from the shelves (22). The elevator (16) is disposed between the first (24L1) and second (24L2) pairs of waiting stations. The elevator (16) comprises a first elevating platform (30L) for receiving load (P) from the waiting conveyers (26L). A second elevating platform delivers a load (P) and receives a load (P) from the waiting conveyors at each of the other of the first pair of waiting stations (24L1) and the other of the second pair (24L2) of waiting stations. The first conveyor delivers and receives a load (P) from the first elevating platform (30L). The second conveyor delivers and receives a load (P) from the second elevating platform.
Patent NZ-612629-A (NZ)
Title: Apparatus for facing products
Inventor: DAW CONWAY
IPC: A47F7/28
Filed: 2011-12-19
Abstract: Disclosed is a kit for aligning and drawing one or more objects across a support surface (3), such as a display shelf. The kit comprises a container (28), a riser (1) and a spacer element. The container (28) has an opposing pair of side walls (see 34, figure 4b) and an opposing pair of end walls for aligning objects therein. The riser (1) is arranged to be secured adjacent an edge of the support surface (3). The spacer element is configured to maintain a product spaced apart from the end element (1). The spacer element is configured to provide a zone (see 22, figure 4b) to accommodate an end wall of the container (28). In use, the container may be pulled forward to pull stock, such as wine bottles, forward on a shelf.
Patent NZ-613634-A (NZ)
Title: Method for producing coffee extract
Inventor: YOKOO YOSHIAKI
IPC: A47J31/44
Filed: 2011-08-01
Abstract: A method for manufacturing a coffee extract, the method comprising the steps of placing coffee granules M in a granule container part 2 wherein the coffee granules M are substantially sealed within the granule container part 2, introducing an extraction solvent 5 from a first direction into the granule container part 2 wherein the extraction solvent is brought in contact with the coffee granules M, allowing extraction to occur, and retrieving, from the first direction, the coffee extract from the granule container part wherein the coffee granules are substantially sealed in a second direction, which is opposite of the first direction, by a restraining member 11 placed in abutting contact with or in close proximity to a surface of deposited layers of the coffee granules M. The coffee extract is retrieved by introducing water from the second direction into the granule container part.
Patent NZ-617815-A (NZ)
Title: Methods and devices for the detection of hypopnea
Inventor: ARMITSTEAD JEFFREY PETER
IPC: A61M16/00
Filed: 2010-05-21
Abstract: A method for controlling a processor to detect a hypopnea is disclosed. The processor receives a measured flow of breathable gas and a long-term measure of ventilation based on the measured flow of breathable gas id determined. A short-term measure of ventilation based on the measured flow of breathable gas and a threshold as a proportion of the long-term measure of ventilation are determined. An area bounded by first and second crossings of the short-term measure of ventilation and the threshold is measured and the hypopnea is detected based on an extent of the measured area.
Patent NZ-618376-A (NZ)
Title: Fuel composition
Inventor: NIELSEN JENS MOGENS
IPC: C10L1/198
Filed: 2012-06-29
Abstract: Disclosed herein is a fuel composition comprising: (a) a fuel; and (b) a polyglycerol ester of a fatty acid wherein the polyglycerol ester of a fatty acid is present in an amount of no greater than 0.5 weight% based on the total fuel composition; and wherein the polyglycerol composition used to form the polyglycerol ester of a fatty acid comprises a mixture of diglycerol in an amount of 11.0 to 34.0 weight% based on the combined weight of the polyglycerols; triglycerol in an amount of 9.5 to 24.5 weight% based on the combined weight of the polyglycerols; tetraglycerol in an amount of 6.0 to 21.0 weight% based on the combined weight of the polyglycerols; pentaglycerol in an amount of 3.5 to 19.0 weight% based on the combined weight of the polyglycerols; hexaglycerol in an amount of 6.0 to 13.5 weight% based on the combined weight of the polyglycerols; heptaglycerol in an amount of 5.0 to 13.0 weight% based on the combined weight of the polyglycerols; octaglycerol in an amount of 3.0 to 12.0 weight% based on the combined weight of the polyglycerols; nonaglycerol in an amount of 1.5 to 10.0 weight% based on the combined weight of the polyglycerols; decaglycerol in an amount of 0.0 to 8.0 weight% based on the combined weight of the polyglycerols; and unadecaglycerol in an amount of 0.0 to 7.0 weight% based on the combined weight of the polyglycerols. Also disclosed is a method for improving the stability of a fuel composition containing fuel and water using the polyglycerol ester fuel compositions.
Patent NZ-629034-A (NZ)
Title: A rotary milking platform
Inventor: HARTY JOHN
IPC: A01K1/12
Filed: 2011-02-09
Abstract: A rotary milking platform (1) comprises a circular platform (2) which defines a plurality of animal accommodating locations (bails) (3) for accommodating animals (4) during milking. The accommodating locations are disposed side by side circumferentially around the periphery (6) of the platform (2). A plurality of milking apparatus (indicated generally by 10), are located beneath the rotary milking platform (1) adjacent the respective animal accommodating locations (3) for presenting teat cups (16) for attaching to the teats of animals in the respective corresponding animal accommodating locations for milking of the animals. The platform 11 of each apparatus 10 comprises a support plate (12) having upwardly extending opposite end walls (9). The platform 11 defines an upwardly facing major surface (26) on which the animal stands during milking. The teat cup carrier (15) of each apparatus (10) is pivotal between a first state in which the teat cups (16) extend substantially horizontally, and in which the teat cups (16) may be held in a protected state; and a second state with the teat cups (16) in a ready state oriented substantially vertically with respective open mouths (18) of the teat cups (16) facing upwardly ready for urging by hand from the teat cup carrier (15) into engagement with the teats of the corresponding one of the animals (4).
Patent NZ-631405-A (NZ)
Title: Combination of anti-kir antibodies and anti-pd-1 antibodies to treat cancer
Inventor: GRAZIANO ROBERT F
IPC: C07K16/28
Filed: 2013-10-02
Abstract: Disclosed is a combination of: (a) an anti-PD-1 antibody comprising the CDR1, CDR2 and CDR3 domains in a heavy chain variable region having the sequence set forth in SEQ ID NO:19, and the CDR1, CDR2 and CDR3 domains in a light chain variable region having the sequence set forth in SEQ ID NO:21; and (b) an anti-KIR antibody comprising the CDR1, CDR2 and CDR3 domains in a heavy chain variable region having the sequence set forth in SEQ ID NO:3, and the CDR1, CDR2 and CDR3 domains in a light chain variable region having the sequence set forth in SEQ ID NO:5; wherein the anti-PD-1 antibody and the anti-KIR antibody are formulated for co-administration to a patient afflicted with cancer in at least one cycle, wherein the dosing schedule for co-administration to the patient includes two doses of the anti-KIR antibody at a dose of 0.1, 0.3, 1, 3, 6, or 10 mg/kg, and four doses of the anti-PD-1 antibody at a dose of 3 mg/kg.
Patent NZ-704178-A (NZ)
Title: Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
Inventor: CISKE FRED LAWRENCE
IPC: C07D403/12
Filed: 2013-07-19
Abstract: Disclosed herein are compounds of formula (I) and therapeutic methods of treatment with compounds of formula (I), wherein L1, L2, L4, R1, R4, R5, R6, and s are as defined in the specification. Compounds of formula (I) are EP4 agonists useful in the treatment of glaucoma, neuropathic pain, and related disorders.
Patent NZ-709219-A (NZ)
Title: Gel compositions
Inventor: GONZÁLEZ OJER CARLOS
IPC: C08L33/02
Filed: 2013-12-16
Abstract: The present invention provides a gel combination comprising: polycarbophil in an amount comprised from 1 to 5% by weight; polyvinylpyrrolidone in an amount comprised from 4 to 8% by weight; glycerine in an amount comprised from 1 to 10% by weight; and propyleneglycol in an amount comprised from 20 to 40% by weight; wherein: the weight ratio between polyvinylpirrolidone:polycarbophil is comprised between 1:1 and 4:1, the weight ratio between glycerine:polycarbophil is comprised from 0.5:1 to 2:1, and the weight ratio propyleneglycol:polycarbophil is comprised from 8:1 to 20:1. The invention also provides transparent compositions comprising such gel combinations as well as processes for their preparation and the use thereof as a medicament. Due to the specific excipients, % by weight, and weight ratios forming the combination, the resulting compositions show a high bioadhesivity and bioavailablity of the active ingredient, without toxic adverse effects.
Patent NZ-766463-A (NZ)
Title: User equipment and base station
Inventor: HARADA HIROKI
IPC: H04W76/10
Filed: 2018-01-11
Abstract: In order to efficiently notify user equipment of available resources during an initial access of a radio communication system without constraints on the allocation of SS burst sets, a terminal is provided and comprises: a receiver that receives an index specifying a configuration of a RACH resource in a radio frame; a controller that identifies a RACH resource based on the index; and a transmitter that transmits a random access preamble using the RACH resource, wherein the configuration of the RACH resource includes a time domain location and a number of the RACH resource specified by the index, and wherein the configuration of the RACH resource includes a configuration in which the RACH resource is allocated only in a latter half of the radio frame.
Patent PT-102170-A (PT)
Title: Window blind box for civil construction
IPC: E06B9/00
Filed: 1998-06-17
Abstract: The invention refers to a window blind box for civil construction and is composed of a base, two perpendicular walls and two ends. The exterior portions of the walls have a height of 28 cm, 1, and 31 cm, 2, and thickness of 4.2 cm, the base at the bottom of the box 3 has width of 31 cm by depth of 4.2 cm, the ends have height of 31 cm and width of 31 cm, 4, with a recess of 3 cm. At the vertical walls and base there is an overhang of 2 cm where it has plates of esferovite or rofemeite. The entire box is made from "leca", containing a network of sol, cement and sand, the whole cast simultaneously. On the inside the dimensions of the box are 23.8 cm by 22.6 cm by 26.8 cm. <IMAGE>